Rapid Micro Biosystems, Inc.

RPID Healthcare Medical Devices

Rapid Micro Biosystems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $33.6 million, up 19.7% from fiscal 2024.

Revenue
+10.9%
EPS
0.00%
Free cash flow
−24.0%

Quarter to June 2026, against a year earlier

0.64 0.02 +3.23%
Market cap
$31.1M
P/E
0.0×
Fwd P/E
−0.8×
Dividend yield
—
F-score
3/9
Altman Z
−8.86
Beneish M
−5.06
Dividend safety
n/a

Rapid Micro Biosystems, Inc. (RPID) P/E ratio

Alert me on P/E ratio

Rapid Micro Biosystems, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
22 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

Company P/E ratio
TELA TELA Bio, Inc. compare n/m
CVRX CVRx, Inc. compare n/m
RPID Rapid Micro Biosystems, Inc. n/m
QTI QT Imaging Holdings, Inc. compare n/m
NNOX Nano-X Imaging Ltd. compare n/m
NSPR InspireMD, Inc. compare n/m
XTNT Xtant Medical Holdings, Inc. compare n/m
ELUT Elutia Inc. compare 0.6×
NSYS Nortech Systems Incorporated compare 28.4×
Medical Devices industry median 25.6×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on RPID